For professionals

Contact

Five kinds of question. One address.

Clinicians, distributors, pharmacies, patients and press: tell us who you are, and your message goes to the people best placed to answer it.

Illustration in botanical-plate style: two envelopes. The front one is closed with a red wax seal stamped with the Ankaferd drop, with a sprig of thyme tucked beneath it. ABS ENQUIRIES · ANKAFERD.INFO · For the right desk —
Fig. 1Every enquiry is routed by type. Illustrative.

  • Suspected side effect? Use the dedicated safety contact, not the form. How to report

  • Medical emergency? Call 112 (Türkiye and the EU) or your local emergency number. This form is not monitored around the clock.

  • Instructions for Use and product information for professionals. HCP resources

Enquiry form

Write to us.

Three short steps. We only ask for what we need to reply.

Routed by type, read by a person, answered within 2 working days.

  1. Routed by typeYour choice in step 1 decides which team reads your message.
  2. Read by a personA member of the relevant team reviews every enquiry.
  3. AnsweredUsually within 2 working days, in German or English.

Prefer e-mail?

kontakt@ankaferd.info

Fields marked with an asterisk are required.

What is your enquiry about?

Choose the one that fits best. It changes the questions in step 2.

About you

We'll only use it to reply to you.

Include the country code, e.g. +90.

For healthcare professionals

For distributors

Countries or regions, e.g. “Germany, Austria”.

For pharmacy and procurement

Helps us route a quote request. Pack sizes are listed on the product information sheet.

We can’t give personal medical adviceAnkaferd Blood Stopper® is intended for professional / medical use. For questions about your own treatment, please speak to your doctor, dentist or pharmacist. To report a suspected side effect, use the safety contact.

For press and media

Your message

At least 20 characters. Please don’t include patient-identifiable information.

Prototype: submissions are simulated and nothing is sent yet.

For healthcare professionals

Resources for clinicians.

The Instructions for Use are the authority on indications, application and precautions. Everything on this website is secondary to them.

Document · PDF, to be supplied

Product information sheet

Composition of the five plant extracts, available forms, pack sizes and storage, on one page.

Languages
EN, TR
Version
Rev. —

Not yet available to download

Request a copy by e-mail

Also on this site

  1. How to apply

    Step-by-step application for Push & Stop, plus a note on the absorbable wound dressing.

  2. Evidence library

    Every publication we cite, filterable by clinical area and study design.

  3. Safety profile

    Toxicology screens, biocompatibility, and what is still debated.

  4. Frequently asked questions

    Short answers on forms, mechanism and use.

Avoid exposed neural tissuePotential neurotoxicity has been reported in rodents, and the neurotoxic potential after direct nerve exposure is debated⁠1. Avoid direct application on exposed neural tissue, and follow the Instructions for Use. (IFU wording to be confirmed)

Where to buy

Find a distributor.

Choose a region to see listed partners. The partner list is still being compiled, so every entry below is a clearly marked placeholder.

Fig. 2Regions are grouped for orientation only, not political statements. Map data: Natural Earth (public domain). Illustrative.

Regions

Türkiye

Approved by the Turkish Ministry of Health for local applications in dental and superficial bleeding⁠1.

Europe & Central Asia

CE-marked medical device (Class III, Directive 93/42/EEC, notified body TSE); on the EU market and distributed in Germany.

Middle East & North Africa

Regulatory status in this region: to be confirmed.

  • No partner listed

    No distributor has been confirmed for this region yet.

  • Distribute in the Middle East & North Africa?

    Tell us about your company and the territories you cover.

    Apply as a distributor

Sub-Saharan Africa

Regulatory status in this region: to be confirmed.

  • No partner listed

    No distributor has been confirmed for this region yet.

  • Distribute in Sub-Saharan Africa?

    Tell us about your company and the territories you cover.

    Apply as a distributor

Asia–Pacific

Regulatory status in this region: to be confirmed.

  • No partner listed

    No distributor has been confirmed for this region yet.

  • Distribute in Asia–Pacific?

    Tell us about your company and the territories you cover.

    Apply as a distributor

Americas

Regulatory status in this region, including FDA: to be confirmed.

  • No partner listed

    No distributor has been confirmed for this region yet.

  • Distribute in the Americas?

    Tell us about your company and the territories you cover.

    Apply as a distributor

Pharmacovigilance

Report a suspected side effect.

If you think Ankaferd Blood Stopper® caused an unwanted effect, or a product did not perform as expected, please tell us. Reports from patients and healthcare professionals help keep every product safer.

In a medical emergency, call 112 (Türkiye and the EU) or your local emergency number first.

Safety desk

Please don’t use the general enquiry form for safety reports. You can also report to the competent authority in your country; in Germany that is the BfArM (Federal Institute for Drugs and Medical Devices), and in Türkiye the TİTCK (Turkish Medicines and Medical Devices Agency).

What to include

  1. The product, and its batch or lot number if you have it.
  2. What happened, and when it started.
  3. Where and how the product was applied.
  4. Other medicines or treatments involved.
  5. How we can contact you for follow-up questions.

You don’t need to be certain the product caused the effect to report it.

Company

Company details.

The full statutory information is in the imprint. Personal data is handled as described in the privacy notice.

Legal entity
Health & Beauty GmbH
Registered office
Weinstraße 3
80333 München, Germany
Commercial register
Amtsgericht München, HRB 132037
VAT ID
DE814696594
Managing directors
Dr. med. Friedrich Krieg, Dr. Roland Krieg
General e-mail
kontakt@ankaferd.info
Distributor enquiries
distribution@ankaferd.info
Office hours
Monday to Friday, 9:00–12:00
Website languages
German, English, Dutch, Swedish and Slovak.
References on this page (1)
  1. [1]Tibi SE, et al. Beyond hemostasis: a narrative review on the multifaceted therapeutic potential of Ankaferd Blood Stopper. Ann Med Surg. 2025/26;88(1):522–533. doi:10.1097/MS9.0000000000004388